Alexandria Aktie
WKN: 908918 / ISIN: EGS38341C011
30.04.2025 00:07:12
|
Why Alexandria Real Estate Stock Tumbled on Tuesday
Investors were bearish on the equity of Alexandria Real Estate Equities (NYSE: ARE) throughout Tuesday's trading session. After the office space-focused real estate investment trust (REIT) reported its latest quarterly results, its stock fell and continued to wallow. It closed the day almost 6% lower in price. Meanwhile, the benchmark S&P 500 (SNPINDEX: ^GSPC) crawled 0.6% higher.For its first quarter of 2025, Alexandria's total revenue came in at just under $758 million. This was down some distance from the $769 million of the same period in 2024. The company's net loss according to generally accepted accounting principles (GAAP) was $11.6 million, or $0.07 per share. That was quite the shift from the first quarter 2024's nearly $167 million profit.However, funds from operations (FFO) is considered a truer yardstick for a REIT's profitability. Alexandria was well in the black on that metric, although it suffered a year-over-year fall to $392 million ($2.30 per share) from almost $404 million.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Alexandria Co. for Pharmaceuticals & Chemical Industriesmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Real Estate Corp Ltdmehr Analysen
Aktien in diesem Artikel
Alexandria Co. for Pharmaceuticals & Chemical Industries | 430,15 | -2,46% |
|